Latest filing published 24 Aug 2026 for CU6.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
listed in Annexure A) discloses dealings in Clarity Pharmaceuticals Ltd to ASX. We count 2 filings; the first trade dates from 6 July 2026 and the latest from 19 August 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 24 August 2026 with a transaction in Clarity Pharmaceuticals Ltd. This summary is built from ASX disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations